Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Business combination agreement (Tables)

v3.22.2.2
Business combination agreement (Tables)
12 Months Ended
Sep. 30, 2022
Business combination agreement  
Schedule of fair value of deemed shares issued

    

Valuation

 

    

Fair value

    

technique

    

Unobservable input

    

Range

485,326 Ordinary Shares in Arqit Limited deemed issues in reverse acquisition

$

223,517,945

Market comparable companies

Revenue multiple

12-17 x

 

 

EBITDA multiple

 

20-30 x

 

uFCF multiple

 

20-25 x

 

Revenue growth rate (CAGR)

 

9.1

%

Discount

20

%

Schedule of fair value of net assets acquired

    

$

Cash and cash equivalents

 

107,035,478

Trade and other receivables

1,961,889

Warrant liabilities

 

(29,948,361)

Trade and other payables

 

(11,000,000)

Net assets

 

68,049,006

Schedule of other reserves arise as a result of the reverse acquisition

$

Pre-acquisition losses of AQI

(18,237,443)

Pre-acquisition reserves of AQI

26,285,329

AL share capital at acquisition

269

AL share premium at acquisition

20,210,904

Reverse acquisition expense

155,459,939

Transaction costs

(16,914,223)

166,804,775

Summary of exceptional costs disclosed within the consolidated statement of comprehensive income

The exceptional costs within the Consolidated Statement of Comprehensive Income for the year ended 30 September 2021 comprised:

    

$

Reverse acquisition expense

155,459,939

Other listing expenses

2,589,611

158,049,550